A randomised, double-blind, parallel-group, placebo-controlled study to evaluate the changes in inflammatory markers in induced sputum following treatment with tiotropium inhalation capsules 18mcg once daily in patients with chronic obstructive pulmonary disease

Trial Profile

A randomised, double-blind, parallel-group, placebo-controlled study to evaluate the changes in inflammatory markers in induced sputum following treatment with tiotropium inhalation capsules 18mcg once daily in patients with chronic obstructive pulmonary disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Feb 2007

At a glance

  • Drugs Tiotropium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 17 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top